ondansetron has been researched along with Bulimia in 7 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Key terms included ondansetron, bulimia nervosa, binge eating, and eating disorders." | 8.81 | Treatment of bulimia nervosa with ondansetron. ( Ferrill, MJ; Fung, SM, 2001) |
| "Ondansetron is a peripherally active antagonist of the serotonin receptor 5-HT3, and is marketed for prevention of vagally-mediated emesis caused by cancer chemotherapeutic agents." | 6.69 | Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. ( Banerjee-Stevens, D; Daughters, RS; Eckert, ED; Faris, PL; Goodale, RL; Hartman, BK; Hofbauer, RD; Kim, SW; Marshall, AM; Meller, WH; Oakman, SA, 2000) |
| " The present study was aimed at determining (1) if pressure pain detection thresholds (PDT) varied dynamically with the primary disease symptoms of binge eating and vomiting and (2) if the elevation in PDT was effected by treatment with ondansetron (ONDAN), a 5-HT3 receptor antagonist." | 5.08 | Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviors and pain thresholds. ( Eckert, ED; Faris, PL; Goodale, RL; Hartman, BK; Hofbauer, RD; Howard, LA; Meller, WH; Oakman, SA; Stevens, ER; Won Kim, S, 1998) |
| " Key terms included ondansetron, bulimia nervosa, binge eating, and eating disorders." | 4.81 | Treatment of bulimia nervosa with ondansetron. ( Ferrill, MJ; Fung, SM, 2001) |
| "Ondansetron is a peripherally active antagonist of the serotonin receptor 5-HT3, and is marketed for prevention of vagally-mediated emesis caused by cancer chemotherapeutic agents." | 2.69 | Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. ( Banerjee-Stevens, D; Daughters, RS; Eckert, ED; Faris, PL; Goodale, RL; Hartman, BK; Hofbauer, RD; Kim, SW; Marshall, AM; Meller, WH; Oakman, SA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, AS | 1 |
| Hartman, BK | 3 |
| Faris, PL | 3 |
| Kim, SW | 2 |
| Raymond, NC | 1 |
| Goodale, RL | 3 |
| Meller, WH | 3 |
| Eckert, ED | 3 |
| Won Kim, S | 1 |
| Hofbauer, RD | 2 |
| Oakman, SA | 2 |
| Howard, LA | 1 |
| Stevens, ER | 1 |
| Kiss, A | 1 |
| Marshall, AM | 1 |
| Daughters, RS | 1 |
| Banerjee-Stevens, D | 1 |
| Hasler, WL | 1 |
| Fung, SM | 1 |
| Ferrill, MJ | 1 |
1 review available for ondansetron and Bulimia
| Article | Year |
|---|---|
Treatment of bulimia nervosa with ondansetron.
Topics: Administration, Oral; Adult; Bulimia; Clinical Trials as Topic; Female; Humans; Ondansetron; Seroton | 2001 |
2 trials available for ondansetron and Bulimia
| Article | Year |
|---|---|
Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviors and pain thresholds.
Topics: Adult; Bulimia; Feeding Behavior; Female; Humans; Middle Aged; Nociceptors; Ondansetron; Pain Thresh | 1998 |
Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
Topics: Adolescent; Adult; Afferent Pathways; Antiemetics; Bulimia; Double-Blind Method; Feeding Behavior; F | 2000 |
4 other studies available for ondansetron and Bulimia
| Article | Year |
|---|---|
Academy for Eating Disorders International Conference on Eating Disorders. Denver, CO, USA, May 29-31, 2003.
Topics: Anti-Obesity Agents; Antidepressive Agents, Tricyclic; Bulimia; Fructose; Humans; Ondansetron; Serot | 2003 |
Treatment of bulimia nervosa with ondansetron.
Topics: Adult; Bulimia; Drug Administration Schedule; Female; Humans; Ondansetron; Synaptic Transmission; Tr | 1997 |
Treatment of chronic bulimic symptoms: new answers, more questions.
Topics: Antiemetics; Bulimia; Chronic Disease; Female; Follow-Up Studies; Humans; Ondansetron; Serotonin Ant | 2000 |
5-HT(3) antagonist therapy of bulimia nervosa: a peripherally active agent for a central nervous system eating disorder?
Topics: Adult; Bulimia; Double-Blind Method; Female; Humans; Ondansetron; Randomized Controlled Trials as To | 2000 |